Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial

OBJECTIVES: To investigate the potential efficacy of Nigella sativa (NS) oil supplementation on the outcomes of patients with mild Coronavirus Disease 2019 (COVID-19). TRIAL DESIGN: Prospective, two-arm, parallel-group, randomised (1:1 allocation ratio), open-label, controlled, exploratory phase II...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshak, Abdulrahman E., Koshak, Emad A., Mobeireek, Abdullah F., Badawi, Mazen A., Wali, Siraj O., Malibary, Husam M., Atwah, Ali F., Alhamdan, Meshari M., Almalki, Reem A., Madani, Tariq A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414256/
https://www.ncbi.nlm.nih.gov/pubmed/32771034
http://dx.doi.org/10.1186/s13063-020-04647-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414256/
https://www.ncbi.nlm.nih.gov/pubmed/32771034
http://dx.doi.org/10.1186/s13063-020-04647-x

Ejemplares similares